DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Pilot trial of N-acetylcysteine and tigecycline as a catheter-lock solution for treatment of hemodialysis catheter-associated bacteremia.

Author(s): Aslam S, Trautner BW, Ramanathan V, Darouiche RO

Affiliation(s): Sections of Infectious Disease, Department of Medicine, Baylor College of Medicine, the Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA. saslam@bcm.tmc.edu

Publication date & source: 2008-09, Infect Control Hosp Epidemiol., 29(9):894-7.

Publication type: Clinical Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

We evaluated a catheter-lock solution consisting of N-acetylcysteine, tigecycline, and heparin for catheter salvage in patients with hemodialysis catheter-associated bacteremia. Eighteen case patients received the catheter-lock solution for 14 days plus systemic antibiotic therapy. Treatment was successful for 15 (83%) of the 18 case patients within 90 days of follow-up, with a median catheter retention interval of 64.5 days.

Page last updated: 2009-02-08

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017